Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

The four photos, by artist Sally Mann, were taken down from the show Diaries of Home weeks ago. But neither police nor museum ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease. However, these few ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...

The Division of Cancer has a focus on the translation of high-quality basic research into clinical studies leading to stratified and personalised cancer treatment approaches, which will change NHS ...

which involved data from the National Cancer Institute, the US Centers for Disease Control and Prevention and the North American Association of Central Cancer Registries. “We see for the first ...

interim chair of medical oncology at the Dana-Farber Cancer Institute in Boston. The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset ...

Kamal, an oncologist and former researcher at the Duke Cancer Institute, says women should pay attention to weight gain, particularly later in life. Because of hormonal changes in perimenopause and ...

Shanghai has entered preliminary talks with American singer-songwriter Taylor Swift about a potential concert this year, according to a local tourism official, as Chinese cities aim to attract ...

Her announcement “certainly is good news and is reassuring,” said Dr. Kimmie Ng, associate chief of the division of gastrointestinal oncology at the Dana-Farber Cancer Institute in Boston.

Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer with residual invasive ... version 9.4 (SAS Institute). The median follow-up was 101.4 months (range ...